33 results
8-K
EX-3.2
BTAX
Biostax Corp.
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
9:00am
, whether by reason of death, resignation, removal, or an increase in the number of directors, may be filled by the affirmative vote of the majority … successor is duly elected and qualified, or until his or her death, resignation or removal.
Section 3. Removal. Any officer, elected or appointed, may
PRE 14C
BTAX
Biostax Corp.
16 Dec 22
Preliminary information
4:31pm
of the Corporation shall hold office until his death, or his resignation or removal from office, or the election and qualification of his successor
8-K
EX-99.1
BTAX
Biostax Corp.
22 Oct 20
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
4:33pm
as a medical radiation countermeasure for preventing death from acute radiation syndrome and, through its joint venture with Everon Biosciences, LLC – Genome
8-K
EX-10.1
tl0k07 ru9pua6l4y
27 Jul 20
Departure of Directors or Certain Officers
3:07pm
8-K
EX-10.1
45g91tz
25 Sep 19
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
rpuaf
11 Jun 18
Entry into a Material Definitive Agreement
12:00am
10-K
18g1h d4rerr
31 Mar 14
Annual report
12:00am
10-12G/A
8n6dgv7hogmpsiio
7 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-10.3
0n7dy 0osx08gvl787l
23 Jan 14
Registration of securities (amended)
12:00am